Field Evaluation of Fungicides for the Management of Neofabraea Leaf Lesion of Olive in California.
Neofabraea
Olea europaea
Phlyctema
chemical control
disease prevention
resistance management
Journal
Plant disease
ISSN: 0191-2917
Titre abrégé: Plant Dis
Pays: United States
ID NLM: 9882809
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
medline:
3
11
2023
pubmed:
31
3
2023
entrez:
30
3
2023
Statut:
ppublish
Résumé
Field experiments were conducted during the fall-winter seasons of 2017 to 2018 and 2018 to 2019 to evaluate the efficacy of various fungicides to control Neofabraea leaf lesion of olive. Field trials were conducted in the highly susceptible cultivar Arbosana in a commercial, super-high-density orchard in San Joaquin County, California. Up to eight fungicidal products were applied using an air blast backpack sprayer, and their efficacy was compared with different application strategies. Results showed that most products were effective in reducing infection by the pathogens and limiting disease severity. Overall, best disease control was achieved by thiophanate-methyl, cyprodinil, difenoconazole + cyprodinil, and chlorothalonil, providing up to 75% reduction in disease severity. Copper hydroxide did not control the disease. In 2018 to 2019, the fungicides difenoconazole + cyprodinil and ziram were evaluated in additional field trials using different application strategies (single, dual, and combined applications) suitable for pathogen resistance management. Results showed that both products provided significant reduction in disease severity (∼50%), although no differences in efficacy were found between the two products nor between the different application strategies. Both products performed equally using one or two applications at 2-week intervals following harvest.
Identifiants
pubmed: 36995771
doi: 10.1094/PDIS-12-22-2896-RE
doi:
Substances chimiques
Fungicides, Industrial
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3079-3084Déclaration de conflit d'intérêts
The author(s) declare no conflict of interest.